---
title: "Tranilast - Atopic Dermatitis - 2"
sidebar: mydoc_sidebar
permalink: db07615-mesh-d003876-2.html
toc: false 
---


Path ID: `DB07615_MESH_D003876_2`
{% include image.html url="images/db07615-mesh-d003876-2.png" file="db07615-mesh-d003876-2.png" alt="db07615-mesh-d003876-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C012293 | Tranilast | Drug |
| UniProt:P35354 | Cyclooxygenase-2 | Protein |
| GO:0001516 | Prostaglandin biosynthetic process | BiologicalProcess |
| MESH:D016207 | Cytokines release | BiologicalProcess |
| MESH:D044062 | Prostaglandins I | ChemicalSubstance |
| GO:0006954 | Inflammatory response | BiologicalProcess |
| MESH:D003876 | Atopic dermatitis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Tranilast | DECREASES ACTIVITY OF | Cyclooxygenase-2 |
| Cyclooxygenase-2 | DECREASES ACTIVITY OF | Prostaglandin Biosynthetic Process |
| Prostaglandin Biosynthetic Process | DECREASES ABUNDANCE OF | Prostaglandins I |
| Tranilast | DECREASES ACTIVITY OF | Cytokines Release |
| Cytokines Release | AMELIORATES | Inflammatory Response |
| Prostaglandins I | AMELIORATES | Inflammatory Response |
| Inflammatory Response | CORRELATED WITH | Atopic Dermatitis |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB07615](https://go.drugbank.com/drugs/DB07615)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Tranilast#section=MeSH-Pharmacological-Classification](https://pubchem.ncbi.nlm.nih.gov/compound/Tranilast#section=MeSH-Pharmacological-Classification)
  - [https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1527-3466.1998.tb00359.x](https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1527-3466.1998.tb00359.x)
  - [https://newdrugapprovals.org/2020/02/28/tranilast/](https://newdrugapprovals.org/2020/02/28/tranilast/)
